News
Autologous mononuclear cells showed substantial activity in patients with advanced heart failure — and even though the study ...
16h
News Medical on MSNNectin4-targeted VHH-CAR-T cells show potency against bladder cancerAnnouncing a new article publication for BIO Integration journal. Bladder cancer (BLCA) is one of the most common malignancies and the second most frequent urogenital tract tumor.
But not all cord blood units are equal – the Nature Medicine study pinpointed key factors that drive NK cell potency. Units with fewer nucleated red blood cells and collection-to ...
Scientists have the technology to grow humans in Petri dishes, but they say there are better uses for it: to combat aging.
Researchers have developed drug-delivering aptamers that can deliver a cytotoxic double punch to leukemic stem cells.
Dr Crystal Mackall Receives IO360 Lifetime Achievement Award for Pioneering Work in T Cell Therapies
The Conference Forum announced that the Immuno-Oncology 360º (IO360º) Summit honored Crystal Mackall, MD, FAAP, FAACR, Stanford University, with the IO360º Lifetime Achievement Award for her ...
Rapid, accurate assays to qualify engineered T-cells’ potency against the target tumor cell are critical. These assays are key to supporting the effective and efficient development of therapeutics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results